Research Topics
| Peter M A CalverleySummaryAffiliation: University of Liverpool Country: UK Publications
| Collaborators
|
Detail Information
Publications
COPD: early detection and interventionP M Calverley
University Clinical Departments, University Hospital Aintree, Long Lane, Liverpool, United Kingdom
Chest 117:365S-71S. 2000..In this article, some of the important concepts relevant to this process are considered, and some of the present techniques used to intervene in established COPD are reviewed...
Chronic obstructive pulmonary diseaseP M A Calverley
Department of Medicine, University of Liverpool, Liverpool, UK
Lancet 362:1053-61. 2003..Regular review of this guidance is important if future management advances are to be implemented effectively...
Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH studyChristine R Jenkins
Woolcock Institute of Medical Research, Sydney, Australia
Respir Res 10:59. 2009..However, there are only limited data about the influence of GOLD severity staging on the effectiveness of SFC, particularly in patients with milder disease...
Respiratory failure in chronic obstructive pulmonary diseaseP M A Calverley
Dept of Medicine, Clinical Sciences Centre, University Hospital Aintree, Longmoor Lane, Liverpool L9 7AL, UK
Eur Respir J Suppl 47:26s-30s. 2003..More attention should be focused on the prevention of these episodes and identifying the factors which cause early relapse...
Dynamic hyperinflation: is it worth measuring?Peter M A Calverley
School of Clinical Sciences, University Hospital Aintree, Liverpool, UK
Proc Am Thorac Soc 3:239-44. 2006....
Cardiovascular events in patients with COPD: TORCH study resultsPeter M A Calverley
Department of Medicine, University Hospital Aintree, Longmoor Lane, Liverpool, UK
Thorax 65:719-25. 2010....
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trialsPeter M A Calverley
School of Clinical Sciences, Liverpool, UK
Lancet 374:685-94. 2009..We therefore investigated whether roflumilast would reduce the frequency of exacerbations requiring corticosteroids in patients with COPD...
Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? The REACT study protocolPeter M A Calverley
Clinical Science Center, University Hospital Aintree, Liverpool, United Kingdom
Int J Chron Obstruct Pulmon Dis 7:375-82. 2012..Roflumilast is approved to treat severe COPD in patients with chronic bronchitis--and a history of frequent exacerbations--as an add-on to bronchodilators...
Chronic airflow limitation in a rural Indian population: etiology and relationship to body mass indexBiswajit Chakrabarti
Aintree Chest Centre, University Hospital Aintree, Liverpool, UK
Int J Chron Obstruct Pulmon Dis 6:543-9. 2011..As such, this study aimed to explore factors associated with the development of airflow obstruction (AFO) in a rural Indian setting and, using spirometry, study whether underweight is linked to AFO...
Effect of corticosteroids on exacerbations of asthma and chronic obstructive pulmonary diseasePeter M A Calverley
Department of Medicine, University Hospital Aintree, Clinical Sciences Centre, Longmoor Lane, Liverpool L9 7AL, UK
Proc Am Thorac Soc 1:161-6. 2004..However, given the impact of exacerbations on overall quality of life in COPD, even this modest reduction is likely to be clinically important...
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseasePeter M A Calverley
University Hospital Aintree, Liverpool, United Kingdom
N Engl J Med 356:775-89. 2007..Long-acting beta-agonists and inhaled corticosteroids are used to treat chronic obstructive pulmonary disease (COPD), but their effect on survival is unknown...
The volumetric response to bronchodilators in stable chronic obstructive pulmonary diseasePaul P Walker
Division of Infection and Immunity, School of Clinical Sciences, University of Liverpool, Liverpool, United Kingdom
COPD 5:147-52. 2008..We suggest that post-bronchodilator absolute change in FVC provides important additional physiological information when interpreting bronchodilator reversibility testing...
Lung function changes following methacholine inhalation in COPDPaul P Walker
Division of Infection and Immunity, School of Clinical Sciences, University of Liverpool, University Hospital Aintree, Liverpool, UK
Respir Med 103:535-41. 2009....
Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary diseasePeter M A Calverley
Department of Medicine, Clinical Sciences, University Hospital Aintree, Liverpool L97AL, UK
Am J Respir Crit Care Med 176:154-61. 2007..Whether treatment is effective in more severe COPD (GOLD [Global Initiative for Chronic Obstructive Lung Disease] stages III and IV) over a longer period is unknown...
Reported pneumonia in patients with COPD: findings from the INSPIRE studyPeter M A Calverley
Clinical Science Centre, University Hospital Aintree, Longmoor Lane, Liverpool L9 7AL, England
Chest 139:505-12. 2011..We investigated patient characteristics and symptoms occurring before pneumonia reports in the Investigating New Standards for Prophylaxis in Reduction of Exacerbations (INSPIRE) study...
Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary diseaseBipen D Patel
Department of Medicine, University of Cambridge, Cambridge, UK
Am J Respir Crit Care Med 178:500-5. 2008..It is unclear whether airway wall thickening and emphysema make independent contributions to airflow limitation in chronic obstructive pulmonary disease (COPD) and whether these phenotypes cluster within families...
Reducing the frequency and severity of exacerbations of chronic obstructive pulmonary diseasePeter M A Calverley
Department of Medicine, University Hospital Aintree, Clinical Sciences Centre, Longmoor Lane, Liverpool L9 7AL, UK
Proc Am Thorac Soc 1:121-4. 2004..Health status changes mirrored these effects. In summary, combination therapy can effectively prevent exacerbations in patients with more advanced COPD...
One-year treatment with mometasone furoate in chronic obstructive pulmonary diseasePeter M A Calverley
Department of Medicine, University Hospital Aintree, Liverpool, UK
Respir Res 9:73. 2008..031). MF-DPI treatment was well tolerated.Once-daily MF-DPI improved lung function and health status in subjects with moderate-to-severe COPD and was comparable to BID MF-DPI...
Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary diseaseNicola J Stevenson
Department of Medicine, Clinical Sciences Centre, University Hospital Aintree, Longmoor Lane, Liverpool L9 7AL, UK
Am J Respir Crit Care Med 172:1510-6. 2005..CONCLUSIONS: Improvement in operating lung volumes is the principal change seen as a chronic obstructive pulmonary disease exacerbation resolves and increase in inspiratory capacity is a useful guide to a reduction in dyspnea...
What have we learned from large drug treatment trials in COPD?Peter M A Calverley
Division of Infection and Immunity, Clinical Sciences Centre, University Hospital Aintree, Liverpool, UK
Lancet 370:774-85. 2007..Ensuring that these expensive studies are done objectively to the highest standard is an important goal for the next decade...
Development of a population-based screening questionnaire for COPDPeter M A Calverley
University of Liverpool, Liverpool, L9 7AL, UK
COPD 2:225-32. 2005..Dissemination of such tools should raise awareness among at-risk persons and help identify COPD patients in the primary care setting...
Minimal clinically important difference--exacerbations of COPDPeter M A Calverley
Department of Medicine, Clinical Sciences Centre, University Hospital Aintree, Liverpool, UK
COPD 2:143-8. 2005..Existing methodologies for estimating clinically important differences are hard to apply with a binary outcome like this, and more work will be needed to develop a robust approach for dealing with this important clinical variable...
The role of corticosteroids in chronic obstructive pulmonary diseasePeter M A Calverley
Department of Medicine, Clinical Sciences Centre, University Hospital Aintree, Liverpool L9 7AL, United Kingdom
Semin Respir Crit Care Med 26:235-45. 2005..Inhaled corticosteroids are not suitable for monotherapy in COPD but can be helpfully combined with an inhaled bronchodilator in patients with symptomatic disease...
Tuberculosis and its incidence, special nature, and relationship with chronic obstructive pulmonary diseaseBiswajit Chakrabarti
Clinical Sciences Centre, University Hospital Aintree, Liverpool, UK
Int J Chron Obstruct Pulmon Dis 2:263-72. 2007..Patients diagnosed with TB may often have extensive co-morbidity such as COPD and the effect of an underlying diagnosis of COPD on outcomes in TB is also reviewed...
A study of patient attitudes in the United Kingdom toward ventilatory support in chronic obstructive pulmonary diseaseBiswajit Chakrabarti
Clinical Sciences Centre, University of Liverpool, University Hospital Aintree, Liverpool, United Kingdom
J Palliat Med 12:1029-35. 2009....
Is airway inflammation in chronic obstructive pulmonary disease (COPD) a risk factor for cardiovascular events?Peter M A Calverley
Clinical Science Centre, University Hospital Aintree, Liverpool, UK
COPD 3:233-42. 2006..A large multicenter prospective randomized trial (Towards a Revolution in COPD Health [TORCH]) is now ongoing and will examine the effect of fluticasone propionate in combination with salmeterol on all-cause mortality...
Withdrawal from treatment as an outcome in the ISOLDE study of COPDPeter M A Calverley
Department of Medicine, University Hospital Aintree, Liverpool, United Kingdom
Chest 124:1350-6. 2003..To investigate the determinants of patient withdrawal from our study, and the effect of these withdrawals on the outcome of treatment with inhaled corticosteroids in patients with COPD...
The GOLD classification has advanced understanding of COPDPeter M A Calverley
Am J Respir Crit Care Med 170:211-2; discussion 214. 2004
The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromideJadwiga A Wedzicha
Academic Unit of Respiratory Medicine, Royal Free and University College Medical School, University College London, London, UK
Am J Respir Crit Care Med 177:19-26. 2008..Exacerbations are key drivers of morbidity and mortality in chronic obstructive pulmonary disease (COPD)...
Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH studyBartolome R Celli
Tufts University School of Medicine, Pulmonary and Critical Care Division, Caritas St Elizabeth s Medical Center, Boston, MA 02135 2997, USA
Am J Respir Crit Care Med 178:332-8. 2008..Chronic obstructive pulmonary disease (COPD) is characterized by an accelerated decline in lung function. No drug has been shown conclusively to reduce this decline...
Proposal for a multidimensional staging system for chronic obstructive pulmonary diseaseBartolome R Celli
Department of Pulmonary and Critical Care Medicine, Tufts University, Boston, MA 02135, USA
Respir Med 99:1546-54. 2005..Although the staging boundaries were based on existing literature, they have proven useful in predicting survival. We conclude that a multidimensional grading system is useful to assess the impact of COPD...
The effect of bronchodilators and oxygen alone and in combination on self-paced exercise performance in stable COPDAlberto Cukier
Pulmonary Division, Heart Institute InCor, University of Sao Paulo Medical School, Sao Paulo, Brazil
Respir Med 101:746-53. 2007..Clinically relevant improvement is possible when therapies with a different mechanism of action are combined...
Spirometry in chronic obstructive pulmonary diseasePatrick J P Poels
BMJ 333:870-1. 2006
A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary diseaseMaureen P M H Rutten-van Mölken
Institute for Medical Technology Assessment, Erasmus MC, Rotterdam, The Netherlands
Pharmacoeconomics 25:695-711. 2007..This study investigated the cost effectiveness of roflumilast in patients with severe to very severe COPD from the perspective of the UK society and UK NHS...
Pathological networking: a new approach to understanding COPDIan Sabroe
Academic Unit of Respiratory Medicine, L Floor, Royal Hallamshire Hospital, Sheffield S10 2JF, UK
Thorax 62:733-8. 2007....
